ArticleThe journal of allergy and clinical immunology. In practice2022

The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience.

Cassandra Rush et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.